OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
OrthoPediatrics (Nasdaq: KIDS) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call the same day at 4:30 p.m. ET, with a live and archived webcast available on its website for at least 90 days.
Details
News Market Reaction – KIDS
On Jul 22, the first trading day after this news, KIDS closed 1.18% below the previous close.
Data tracked by StockTitan Argus for the Jul 22 session.
Key Figures
- Results Release Date
- August 4, 2026
- Second quarter 2026 financial results
- Conference Call Time
- 4:30 p.m. ET
- August 4, 2026
- Replay Availability
- At least 90 days
- Webcast replay after the event
Previous Earnings date Reports
-
Scheduled first-quarter results release and conference call for April 30
-
Scheduled fourth-quarter and full-year results release for February 26
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., July 21, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2026 financial results on Tuesday, August 4, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 4, 2026 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.